期刊
JOURNAL OF MEDICAL MICROBIOLOGY
卷 62, 期 -, 页码 1369-1378出版社
MICROBIOLOGY SOC
DOI: 10.1099/jmm.0.058933-0
关键词
-
类别
资金
- Science Foundation of Ireland (SFI)
- Centre for Science, Engineering and Technology [02/CE/B124]
- SFI
Clostridium difficile infection (CD is a major cause of morbidity and mortality among hospitalized patients and imposes a considerable financial burden on health service providers in both Europe and the USA. The incidence of CDI has dramatically increased in recent years, partly due to the emergence of a number of hypervirulent strains. The most commonly documented risk factors associated with CDIs are antibiotic usage leading to alterations of the gut microbiota, age >65 years and long-term hospital stay. Since standard therapies for antibiotic-associated diarrhoea and CD! have limited efficacy, there is now an urgent need for alternative therapeutics. In this review, we outline the current state of play with regard to the potential of gut-derived bacteriocins, probiotics and phage to act as antimicrobial agents against CDI in the human gut.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据